Latest news with #ArcheanChemicalIndustries
&w=3840&q=100)
Business Standard
6 days ago
- Business
- Business Standard
Archean Chemical surges 12%, stock hits highest level in CY25; here's why
Archean Chemical Industries share price today Shares of Archean Chemical Industries (ACIL) surged 12 per cent to ₹727.80 on the BSE in Wednesday's intra-day trade amid heavy volumes after the government approved the proposal of SiCSem Private Limited, a subsidiary of the company, under India Semiconductor Mission (ISM) to setup a Silicon Carbide (SiC) based Compound Semiconductor fab. The stock price of the smallcap specialty chemicals company traded at its highest level in the calendar year 2025. It had hit a 52-week high of ₹831 on August 22, 2024. At 10:38 AM; ACIL was quoting 9 per cent higher at ₹713 on the BSE. In comparison, the BSE Sensex was up 0.27 per cent at 80,453. The average trading volumes at the counter jumped multi-fold; with a combined 1.81 million shares changing hands on the NSE and BSE. Cabinet approves 4 semiconductor manufacturing units with an outlay of ₹ 4,600 crore The Union Cabinet chaired by Prime Minister Shri Narendra Modi approved four more semiconductor projects under India Semiconductor Mission (ISM) at an investment of ~₹4600 crore, taking total approved projects to 10 with cumulative investments of about ₹1.60 trillion crore across six states. The newly approved projects include SiCSem (Odisha) - in collaboration with Clas-SiC Wafer Fab (UK), will set up India's first commercial Silicon Carbide (SiC) compound semiconductor fab with annual capacity of 60,000 wafers and 96 million packaged units. The proposed products will have applications in Missiles, Defence equipment, Electric Vehicles (EVs), Railway, Fast Chargers, Data Centre racks, Consumer Appliances, and Solar Power Inverters. Given the growing demand of semiconductors in telecom, automotive, datacentres, consumer electronics and industrial electronics, these four new approved semiconductors projects would significantly contribute to making Atmanirbhar Bharat. Market overview – ACIL The management in Q1FY26 earnings conference call said they are witnessing mixed trends across the chemical industry with early signs of recovery in select segments. Inquiry levels are steadily improving, indicating a more favourable business environment in the coming quarters and years ahead. However, the recent tariff uncertainties have obviously held many global MNCs from making decisions while re-evaluating sourcing and investment strategies. The Indian specialty chemicals industry, nevertheless, is poised for significant long-term growth supported by rising domestic consumption, supply chain diversification and government led incentives, etc. Recently, NITI Aayog has released a report in July 2025 outlining a roadmap for India to become a global chemical powerhouse with potential to reach $1 trillion by 2040, ACIL said. The management said they are confident and seeing consistent demand and expect gradual improvement in volumes over the coming quarters. Company Overview Archean Chemical Industries Limited (ACIL) is a specialty chemicals manufacturing company that produces and supplies marine chemicals. The company is engaged in the production and supply of industrial salt, liquid bromine, sulphate of potash (SOP). ACIL serves a range of industries, including agriculture, pharmaceutical, water treatment, aluminium, glass, and textiles.
Business Standard
29-07-2025
- Business
- Business Standard
Archean Chemical Industries consolidated net profit declines 10.41% in the June 2025 quarter
Sales rise 37.46% to Rs 292.36 crore Net profit of Archean Chemical Industries declined 10.41% to Rs 40.19 crore in the quarter ended June 2025 as against Rs 44.86 crore during the previous quarter ended June 2024. Sales rose 37.46% to Rs 292.36 crore in the quarter ended June 2025 as against Rs 212.69 crore during the previous quarter ended June 2024. Particulars Quarter Ended Jun. 2025 Jun. 2024 % Var. Sales 292.36212.69 37 OPM % 26.7133.48 - PBDT 80.9479.20 2 PBT 58.0160.56 -4 NP 40.1944.86 -10
Mint
08-05-2025
- Business
- Mint
Goldman Sachs-owned, DII favourite small-cap stock drops 4%; Axis Securities downgrades it; do you own?
Small-cap stock Archean Chemical Industries declined nearly 4 per cent in intraday trade on the BSE on Thursday, May 8, looking set to extend losses to the third consecutive session. Archean Chemical Industries share price opened at ₹ 603.25 against its previous close of ₹ 605.40 and declined 3.6 per cent to an intraday low of ₹ 583.45. Around 12:45 PM, the small-cap stock traded 2.71 per cent lower at ₹ 589. Equity benchmark Sensex was almost flat at 80,789 at that time. The speciality chemicals company announced its Q4FY25 results after market hours on May 2. The company reported a 2.2 per cent year-on-year (YoY) decline in its profit after tax (PAT) for the quarter to ₹ 58.31 crore from ₹ 59.64 crore in the same quarter last year. Total income, however, increased 12 per cent to ₹ 333.33 crore from ₹ 297.22 crore in Q4FY24. EBITDA in Q4FY25 saw a mild dip, coming at ₹ 101.12 crore from ₹ 101.94 crore in Q4FY24. Brokerage firm Axis Securities downgraded the stock to a "hold" from a "buy", pegging the target price of ₹ 560. Axis pointed out that the company's Q4FY25 consolidated revenue beat its estimate by 17 per cent. However, EBITDA fell short of its estimates by 4 per cent, while the PAT also missed its estimate by 4 per cent. According to Axis Securities, Archean Chemical Industries remains confident in its bromine derivatives project and the strategic acquisition of Oren, which is expected to make a meaningful contribution to the top line in the coming quarters. Moreover, Axis highlighted that the company anticipates sustained strong demand in the industrial salt segment and a recovery in the SOP segment beginning in FY26. Strategic investments have also been made in two UK- and US-based companies, which are expected to unlock new growth opportunities in semiconductors and energy storage, Axis Securities said. (This is a developing story. Please check back for fresh updates.) Read all market-related news here Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions, as market conditions can change rapidly, and circumstances may vary.
Business Standard
03-05-2025
- Business
- Business Standard
Archean Chemical Industries standalone net profit declines 2.23% in the March 2025 quarter
Sales rise 13.54% to Rs 321.77 crore Net profit of Archean Chemical Industries declined 2.23% to Rs 58.31 crore in the quarter ended March 2025 as against Rs 59.64 crore during the previous quarter ended March 2024. Sales rose 13.54% to Rs 321.77 crore in the quarter ended March 2025 as against Rs 283.39 crore during the previous quarter ended March 2024. For the full year,net profit declined 42.63% to Rs 184.92 crore in the year ended March 2025 as against Rs 322.35 crore during the previous year ended March 2024. Sales declined 23.75% to Rs 1013.79 crore in the year ended March 2025 as against Rs 1329.58 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 321.77283.39 14 1013.791329.58 -24 OPM % 27.8331.09 - 31.8134.92 - PBDT 98.2199.77 -2 363.01501.37 -28 PBT 79.5982.30 -3 289.95431.37 -33 NP 58.3159.64 -2 184.92322.35 -43
Business Standard
03-05-2025
- Business
- Business Standard
Archean Chemical Industries consolidated net profit declines 7.03% in the March 2025 quarter
Sales rise 21.72% to Rs 345.58 crore Net profit of Archean Chemical Industries declined 7.03% to Rs 53.54 crore in the quarter ended March 2025 as against Rs 57.59 crore during the previous quarter ended March 2024. Sales rose 21.72% to Rs 345.58 crore in the quarter ended March 2025 as against Rs 283.91 crore during the previous quarter ended March 2024. For the full year,net profit declined 49.17% to Rs 162.15 crore in the year ended March 2025 as against Rs 318.98 crore during the previous year ended March 2024. Sales declined 21.73% to Rs 1041.02 crore in the year ended March 2025 as against Rs 1330.09 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 345.58283.91 22 1041.021330.09 -22 OPM % 25.5530.69 - 30.1834.78 - PBDT 95.8197.39 -2 343.33497.52 -31 PBT 74.6779.72 -6 263.95427.18 -38 NP 53.5457.59 -7 162.15318.98 -49
